Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 16

OrCam Plans $3 billion Valuation in 2021 IPO

December 20, 2020

OrCam Technologies Ltd, founded and run by Prof Amnon Shashua and Ziv Aviram, is set to go public in New York during 2021, reported by

Read More »

Nanox’s Next Generation Radiology Rocks the RSNA 2020!

December 20, 2020

NANO-X IMAGING LTD (NASDAQ: NNOX) successfully demonstrated its Nanox.ARC next-generation x-ray prototype at the 2020 annual conference of the Radiological Society of North America (RSNA),

Read More »

Alpha TAU Medical raises $26 million funding as it moves to Jerusalem

December 12, 2020

Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, finished in June the closing of a Series B equity financing of $26

Read More »

FDA Accepts Atox Bio’s Reltecimod to Treat Suspected Organ Dysfunction/Failure re “Flesh-Eating Disease”

December 12, 2020

The U.S. Food and Drug Administration (FDA) has accepted to Atox Bio’s filing of the New Drug Application (NDA) for Reltecimod with a Prescription Drug

Read More »

Ascento Medical Gives New Hope for Alzheimer’s and Dementia Patients

November 26, 2020

Ascento Medical is a company in the field of Dementia and Alzheimer’s treatment & prevention, using Artificial Intelligence and Machine Learning to optimize a proven

Read More »

KAHR Announces First Patient Dosed in DSP107 Treatment of Solid Tumors Phase 1/2 Clinical Trial

November 26, 2020

Jerusalem based KAHR MEDICAL, a cancer immunotherapy company developing novel multifunctional immuno-recruitment proteins, started treating the first patient in its Phase 1/2 clinical trial (NCT04440735)

Read More »

Raziel Closes Market License Agreement for RZL 012 with Fosun Pharma

November 11, 2020

Raziel Therapeutics, a Pharmaceutical company, is developing a novel synthetic small molecule (NCE) for aesthetics and fat disorders next-generation novel prescription products. Raziel Therapeutics licensed

Read More »

Oramed to Start Pivotal Phase 3 Oral Insulin Studies

November 11, 2020

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company is about to start their Phase 3 Studies for their oral insulin candidate

Read More »

Omnix Medical Raises $8.5 million for its Novel Drug Targeting AMR Bacteria

November 11, 2020

Omnix Medical just raised an additional $8.5 million to bring its promising AMR (antimicrobial resistance) drug, OMN6, for the treatment of hospital-acquired infections, to clinical

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Next »

JLM-BioCity Upcoming Events

More JLM-BioCity events coming soon…

What People Say About JLM-BioCity

Alexander Naslednikov

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

-Alexander Naslednikov, Founder and CEO, Med.me

Tal Or

JLM-BioCity Member Tal Or

One of the best meetups organizations and a very important source of information and connections for startups.

-Tal Or, Co-Founder, ATLASense Biomed Ltd.

Hemda Idel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

– Hemda Idel, founder, SLEEP ASAP

Aviv Marom

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

-Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Aurélie Schwarzbach

Such an interesting lecture and great people attending!

– Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

– Zeev Malyutin, Protein Department Head, Merck KGaA

Gideon Silberman

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

– Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Immanuel Lerner

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

– Immanuel Lerner CEO, Pepticom

Dror Chevion

Dror Chevion Concenter BioPharma

JLM-BioCity’s events are well organized with a professional approach. You can feel a “homey” atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

– Dror Chevion  CEO, Concenter BioPharma

Ian Solomon

Ian Solomon CTO, OmnySense Ltd

The JLM BioCity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

-Ian Solomon CTO, OmnySense Ltd.

Moshe Lebowitz

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

– Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved